ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Catalyst Pharmaceuticals, INC.

Official 2024 U.S. DOL Form 5500 summary for Catalyst Pharmaceuticals, INC. (Catalyst Pharmaceuticals INC. 401(k) Plan · EIN 76-0837053 · PN 001): $16.34M net assets, 182 active participants, and $3.59 per $10,000 (3.59 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorCatalyst Pharmaceuticals, INC.
Filing IdentifierCatalyst Pharmaceuticals INC. 401(k) Plan · EIN 76-0837053 · PN 001
Plan Category & State401(k) Defined Contribution (FL)
Asset-Size Peer Cohort$5M-$25M
Plan Net Assets (2024)$16.34M
Active Participants182
Direct Admin Fee Rate$3.59 per $10,000 (3.59 bps)
Cohort Peer Median$37.06 per $10,000 (37.06 bps)
Primary Recordkeeper / ProviderFidelity Investments
Schedule H Line 4a RemittanceSchedule H Line 4a Late Remittance Reported ($1.23M, often administrative timing)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI